Search results (10)
« Back to PublicationsProstate specific antigen retesting intervals and trends in England: population based cohort study
Journal article
Collins KK. et al, (2025), BMJ Clinical Research Ed, 391
Patient characteristics, serious disease diagnoses, and incidental findings in individuals with non-specific symptoms referred to the Suspected CANcer (SCAN) Pathway: a prospective cohort study in England
Journal article
Friedemann Smith C. et al, (2025), The Lancet Primary Care, 1, 100019 - 100019
Guideline of guidelines: a critical appraisal of the evidence for PSA retesting intervals
Journal article
Collins KK. et al, (2025), BJU International
Co-production and implementation of an evidence collation strategy for a novel point-of-care information resource: Gpevidence.org
Journal article
Treadwell J. et al, (2025), BMJ Evidence Based Medicine
Clinical Prediction Models Incorporating Blood Test Trend for Cancer Detection: Systematic Review, Meta-Analysis, and Critical Appraisal
Journal article
Virdee PS. et al, (2025), Jmir Cancer, 11
Neuropeptide Y and Derivates Are Not Ready for Prime Time in Prostate Cancer Early Detection
Journal article
Maurer J. et al, (2024), European Urology Open Science, 66, 12 - 15
dequacy of clinical guideline recommendations for patients with low-risk cancer managed with monitoring: systematic review
Journal article
Collins KK. et al, (2024), Journal of Clinical Epidemiology, 169
The Association between Blood Test Trends and Undiagnosed Cancer: A Systematic Review and Critical Appraisal
Journal article
Virdee PS. et al, (2024), Cancers, 16
BLOod Test Trend for cancEr Detection (BLOTTED): protocol for an observational and prediction model development study using English primary care electronic health record data.
Journal article
Virdee PS. et al, (2023), Diagn Progn Res, 7